Clinical Trial Update: An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression [Phase 3]

View source ↗

Summary

An international extension study of Corlux (mifepristone) in recurrent psychotic symptoms of psychotic major depression (Phase 3), with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Psychotic Disorders

Drugs mentioned

• CORLUX (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Major Depressive Disorder, Psychotic Disorders | Phase 3 | Status: COMPLETED